Publications

Publications

The role of TREM2 R47H as a risk factor for Alzheimer's disease, frontotemporal lobar degeneration, amyotrophic lateral sclerosis, and Parkinson's disease.

Lill CM, Rengmark A, Pihlstrøm L, Fogh I, Shatunov A, Sleiman PM, Wang LS, Liu T, Lassen CF, Meissner E, Alexopoulos P, Calvo A, Chio A, Dizdar N, Faltraco F, Forsgren L, Kirchheiner J, Kurz A, Larsen JP, Liebsch M, Linder J, Morrison KE, Nissbrandt H, Otto M, Pahnke J, Partch A, Restagno G, Rujescu D, Schnack C, Shaw CE3, Shaw PJ22, Tumani H, Tysnes OB, Valladares O, Silani V, van den Berg LH, van Rheenen W, Veldink JH, Lindenberger U, Steinhagen-Thiessen E; SLAGEN Consortium, Teipel S, Perneczky R, Hakonarson H, Hampel H, von Arnim CA, Olsen JH, Van Deerlin VM, Al-Chalabi A, Toft M, Ritz B, Bertram L. Alzheimers Dement. 2015 Apr 30 [Epub ahead of print].

PMID: 25936935
Striatal cholinergic dysfunction as a unifying theme in the pathophysiology of dystonia

Eskow Jaunarajs KL, Bonsi P, Chesselet MF, Standaert DG, Pisani A. Prog Neurobiol. 2015 Apr; 127-18C:91-107.

PMID: 25697043
Platelet mitochondrial activity and pesticide exposure in early Parkinson's disease.

Bronstein JM, Paul K, Yang L, Haas RH, Shults CW, Le T, Ritz B. Mov Disord. 2015 Mar 11. [Epub ahead of print] 

PMID: 25757798
Social Cognition Impairments in Mice Overexpressing Alpha-Synuclein Under the Thy1 Promoter, a Model of Pre-manifest Parkinson's Disease.

Magen I, Torres ER, Dinh D, Chung A, Masliah E, Chesselet MF. J Parkinsons Disease 2015 Jan 13 [Epub ahead of print] 

 

PMID: 25588356
Intranasal NAP (davunetide) decreases tau hyperphosphorylation and moderately improves behavioral deficits in mice overexpressing α-synuclein.

Magen I, Ostritsky R, Richter F, Zhu C, Fleming SM, Lemesre V, Stewart AJ, Morimoto BH, Gozes I, Chesselet MF.  Pharmacol Res Perspect. 2014 Oct;2(5)

 

PMID: 25505609
AMPK Modulates Tissue and Organismal Aging in a Non-Cell-Autonomous Manner.

Ulgherait M, Rana A, Rera M, Graniel J, Walker DW. Cell Rep. 2014 Sep 25;8(6):1767-80.  

PMID: 25199830
Transgenic Rodent Models to Study Alpha-Synuclein Pathogenesis, with a Focus on Cognitive Deficits.

Hatami A, Chesselet MF.  Curr Top Behav Neurosci. 2014 Sep 14.

PMID: 25218491
Parkinson disease and smoking revisited: Ease of quitting is an early sign of the disease.

Ritz B, Lee PC, Lassen CF, Arah OA.  Neurology. 2014 Sep 12.

PMID: 25217056
APOE, MAPT, and SNCA Genes and Cognitive Performance in Parkinson Disease.

Mata IF, Leverenz JB, Weintraub D, Trojanowski JQ, Hurtig HI, Van Deerlin VM, Ritz, Rausch R, Rhodes SL, Factor SA, Wood-Siverio C, Quinn JF, Chung KA, Peterson AL, Espay AJ, Revilla FJ, Devoto J, Hu SC, Cholerton BA, Wan JY, Montine TJ, Edwards KL, Zabetian CP.  JAMA Neurol. 2014 Sep 1

PMID: 25178429
People with Parkinson's disease and normal MMSE score have a broad range of cognitive performance.

Burdick DJ, Cholerton B, Watson GS, Siderowf A, Trojanowski JQ, Weintraub D, Ritz B, Rhodes SL, Rausch R, Factor SA, Wood-Siverio C, Quinn JF, Chung KA, Srivatsal S, Edwards KL, Montine TJ, Zabetian CP, Leverenz JB.  Mov Disord. 2014 Sep;29(10):1258-64.(Epub 2014 Jul 29).

PMID: 25073717
A GCase Chaperone Improves Motor Function in a Mouse Model of Synucleinopathy.

Richter F, Fleming SM, Watson M, Lemesre V, Pellegrino L, Ranes B, Zhu C, Mortazavi F, Mulligan CK, Sioshansi PC, Hean S, De La Rosa K, Khanna R,Flanagan J, Lockhart DJ, Wustman BA, Clark SW, Chesselet MF. Neurotherapeutics. 2014 Jul 20.

PMID: 25037721
Region specific mitochondrial impairment in mice with widespread overexpression of alpha-synuclein.

Subramaniam SR, Vergnes L, Franich NR, Reue K, Chesselet MF. Neurobiology of Disease. 2014 Jul 10

PMID: 25016198
Axon degeneration and PGC-1α-mediated protection in a zebrafish model of α-synuclein toxicity.

O'Donnell KC1, Lulla A, Stahl MC, Wheat ND, Bronstein JM, Sagasti A. Disease Models & Mechanisms. 2014 May;7(5):571-82.

PMID: 24626988
Drosophila melanogaster as a genetic model system to study neurotransmitter transporters.

Martin CA, Krantz DE. Neurochem Int. 2014 Jul;73C:71-88

PMID: 24704795
The Use of Antidepressant Medication in Parkinson's Disease Patients is not Affected by the Type of Antiparkinson Medication

Krøigård T, Christensen J, Wermuth L, Ritz B, Lassen CF. Journal of Parkinsons Disease. 2014 Jun 11. [Epub ahead of print]

PMID: 24919822
MUL1 acts in parallel to the PINK1/parkin pathway in regulating mitofusin and compensates for loss of PINK1/parkin.

Yun J, Puri R, Yang H, Lizzio MA, Wu C, Sheng ZH, Guo M. Elife (Cambridge). 2014 Jun 4;3

PMID: 24898855
Pesticides and Parkinson's disease: is it in your genes?

Barnhill LM, Bronstein JM.  Neurodegener Dis Manag. 2014;4(3):197-200

PMID: 25095814
Sleep Dysfunction and EEG Alterations in Mice Overexpressing Alpha-Synuclein.

McDowell KA, Shin D, Roos KP, Chesselet MF. J Parkinsons Dis. 2014 May 27

PMID: 24867919
Chronic administration of cholesterol oximes in mice increases transcription of cytoprotective genes and improves transcriptome alterations induced by alpha-synuclein overexpression in nigrostriatal dopaminergic neurons

Richter F, Gao F, Medvedeva V, Lee P, Bove N, Fleming SM, Michaud M, Lemesre V, Patassini S, De La Rosa K, Mulligan CK, Sioshansi PC, Zhu C, Coppola G, Bordet T, Pruss RM, Chesselet MF. Neurobiology of Disease. 2014 Sep;69:263-75

PMID: 24844147
The redistribution of Drosophila vesicular monoamine transporter mutants from synaptic vesicles to large dense-core vesicles impairs amine-dependent behaviors.

Grygoruk A, Chen A, Martin CA, Lawal HO, Fei H, Gutierrez G, Biedermann T, Najibi R, Hadi R, Chouhan AK, Murphy NP, Schweizer FE, Macleod GT, Maidment NT, Krantz DE. J Neurosci. 2014 May 14;34(20):6924-37

PMID: 24828646

Pages